Cleared Traditional

K183324 - Sensititre 20-24 hour Haemophilus influ...

K183324 is the FDA 510(k) clearance for Sensititre 20-24 hour Haemophilus influ... by Thermo Fisher Scientific. It is a Class 2 Microbiology device (product code JWY) cleared through the Traditional 510(k) pathway after a 77-day FDA review.

K183324 · Thermo Fisher Scientific · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2019
Decision
77d
Days
Class 2
Risk

K183324 is an FDA 510(k) clearance for the Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or .... Classified as Manual Antimicrobial Susceptibility Test Systems (product code JWY), Class II - Special Controls.

Submitted by Thermo Fisher Scientific (Oakwood Village, US). The FDA issued a Cleared decision on February 15, 2019 after a review of 77 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Thermo Fisher Scientific devices

Submission Details

510(k) Number K183324 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 2018
Decision Date February 15, 2019
Days to Decision 77 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 102d · This submission: 77d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JWY Manual Antimicrobial Susceptibility Test Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JWY Manual Antimicrobial Susceptibility Test Systems

All 360
Devices cleared under the same product code (JWY) and FDA review panel - the closest regulatory comparables to K183324.
MicroScan Dried Gram Negative MIC/Combo Panels with Eravacycline (ERV) (0.016-32 ug/mL)
K190109 · Beckman Coulter, Inc. · Apr 2019
MTS Gentamicin 0.016 - 256 µg/mL
K190252 · Liofilchem S. R. L. · Mar 2019
MTS Ciprofloxacin 0.002 - 32 µg/mL
K183527 · Liofilchem S. R. L. · Mar 2019
ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL)
K183031 · Biomerieux S.A. · Jan 2019
MTS Tetracycline 0.016 - 256 ug/mL
K183140 · Liofilchem S. R. L. · Jan 2019
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Omadacycline in the dilution range of 0.03-32ug/ml
K183033 · Thermo Fisher Scientific · Jan 2019